Impact of Spiroergometer Parameters as Diagnostic Marker of Cardiac Ischemia in Pts. With Stable Angina Compared to FFR.

Last updated: August 10, 2022
Sponsor: Jena University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Coronary Artery Disease

Thrombosis

Chest Pain

Treatment

N/A

Clinical Study ID

NCT04450459
SMW 08
  • Ages > 18
  • All Genders

Study Summary

In Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection.

Adding of parameters of spiroergometer might help to improve diagnostic accuracy of non invasive exercise testing. Therefore the trial is evaluating diagnostic accuracy of spiroergometric parameters compared to invasive FFR measurement.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • stable Angina (CCS >1-3) with suspected CAD or
  • dyspnoea at exertion NYHA >2 or
  • signs of ischemia within SPECT or exercise electrocardiography
  • willingness to participate in the trial

Exclusion

Exclusion Criteria:

  • Unstable angina or myocardial infarction within the last 2 weeks
  • inability to perform bicycle exercise test
  • significant valvular disease
  • HOCM
  • av- block >I degree
  • asthma bronchiales

Study Design

Total Participants: 100
Study Start date:
January 02, 2019
Estimated Completion Date:
June 30, 2023

Connect with a study center

  • Universityhospital

    Jena, 07747
    Germany

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.